Interestingly, NPM1-RARA was not only limited in variant APL, but also identified in atypical acute myelomonocytic leukemia, CML, cutaneous mastocytosis, and myeloid sarcoma [45, 47–49]. Here, NPM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.